Mechanical allodynia induced by paclitaxel, oxaliplatin and vincristine: Different effectiveness of gabapentin and different expression of voltage - dependent calcium channel α2δ-1 subunit

Biological and Pharmaceutical Bulletin

Volumn 32, Issue 4, 2009, Pages 732-734

  Gauchan, Punam ^a   Andoh, Tsugunobu ^a   Ikeda, Kenichiro ^a   Fujita, Masahide ^a   Sasaki, Atsushi ^a   Kato, Atsushi ^a   Kuraishi, Yasushi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

2 1 subunit; Gabapentin; Oxaliplatin; Paclitaxel; Vincristine

Indexed keywords

GABAPENTIN; MESSENGER RNA; OXALIPLATIN; PACLITAXEL; PROTEIN SUBUNIT; VINCRISTINE; VOLTAGE GATED CALCIUM CHANNEL;

ALLODYNIA; ANALGESIA; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; INHIBITION KINETICS; INJECTION; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SPINAL GANGLION; SPINE;

ADMINISTRATION, ORAL; AMINES; ANALGESICS, NON-NARCOTIC; ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BEHAVIOR, ANIMAL; CALCIUM CHANNELS; CYCLOHEXANECARBOXYLIC ACIDS; GAMMA-AMINOBUTYRIC ACID; GANGLIA, SPINAL; GENE EXPRESSION; INJECTIONS, SPINAL; MALE; MICE; MICE, INBRED C57BL; ORGANOPLATINUM COMPOUNDS; PACLITAXEL; PAIN; PERIPHERAL NERVOUS SYSTEM DISEASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPINAL CORD; VINCRISTINE;

EID: 65149090651     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.32.732     Document Type: Article

References (20)

1. Wolf S., Barton D., Kottschade L., Grothey A., Loprinzi C., Eur. J. Cancer, 44, 1507-1515 (2008).
2. Windebank A. J., Grisold W., J. Peripher. Nerv. Syst., 13, 27-46 (2008).
3. Backonja M., Glanzman R. L., Clin. Ther., 25, 81-104 (2003).
4. Rao R. D., Michalak J. C., Sloan J. A., Loprinzi C. L., Soori G. S., Nikcevich D. A., Warner D. O., Novotny P., Kutteh L. A., Wong G. Y., Cancer, 110, 2110-2118 (2007).
5. Luo Z. D., Calcutt N. A., Higuera E. S., Valder C. R., Song Y. H., Svensson C. I., Myers R. R., J. Pharmacol. Exp. Ther., 303, 1199-1205 (2002).
6. Lynch J. J. 3rd., Wade C. L., Zhong C. M., Mikusa J. P., Honore P., Pain, 110, 56-63 (2004).
7. Matsumoto M., Inoue M., Hald A., Xie W. J., Ueda H., J. Pharmacol. Exp. Ther., 318, 735-740 (2006).
8. Xiao W., Boroujerdi A., Bennett G. J., Luo Z. D., Neuroscience, 144, 714-720 (2007).
9. Ling B., Authier N., Balayssac D., Eschalier A., Coudore F., Pain, 128, 225-234 (2007).
10. Field M. J., Cox P. J., Stott E., Melrose H., Offord J., Su T. Z., Bramwell S., Corradini L., England S., Winks J., Kinloch R. A., Hendrich J., Dolphin A. C., Webb T., Williams D., Proc. Natl. Acad. Sci. U.S.A., 103, 17537-17542 (2006).
11. Luo Z. D., Chaplan S. R., Higuera E. S., Sorkin L. S., Stauderman K. A., Williams M. E., Yaksh T. L., J. Neurosci., 21, 1868-1875 (2001).
12. Field M. J., McCleary S., Hughes J., Singh L., Pain, 80, 391-398 (1999).
13. Takasaki I., Andoh T., Nojima H., Shiraki K., Kuraishi Y., J. Pharmacol. Exp. Ther., 296, 270-275 (2001).
14. Takasu K., Honda M., Ono H., Tanabe M., Br. J. Pharmacol., 148, 233-244 (2006).
15. Fujita M., Andoh T., Saiki I., Kuraishi Y., J. Pharmacol. Sci., 106, 257-263 (2008).
16. Andoh T., Yageta Y., Takeshima H., Kuraishi Y., J. Invest. Dermatol., 123, 196-201 (2004).
17. Cole R. L., Lechner S. M., Williams M. E., Prodanovich P., Bleicher L., Varney M. A., Gu G., J. Comp. Neurol., 491, 246-269 (2005).
18. Ochoa J. L., Yarnitsky D., Ann. Neurol., 33, 465-472 (1993).
19. Sasaki A., Serizawa K., Andoh T., Shiraki K., Takahata H., Kuraishi Y., J. Pharmacol. Sci., 108, 266-273 (2008).
20. Patel M. K., Gonzalez M. I., Bramwell S., Pinnock R. D., Lee K., Br. J. Pharmacol., 130, 1731-1734 (2000).